Patents
Patents for C07D 407 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group (11,963)
05/2000
05/09/2000CA2159786C Dibenzofuran derivatives compounds; pharmaceutical and cosmetic compositions containing the same
05/09/2000CA1340989C Chemiluminescent 1, 2-dioxetane compounds
05/04/2000WO2000024727A1 5,6,7-TRINOR-4,8-INTER-m-PHENYLENE PGI2 DERIVATIVE AND DRUGS CONTAINING THE SAME
05/03/2000EP0632031B1 Condensed benzoxa ring compound, production thereof, and pharmaceutical composition containing the same
05/03/2000CN1052001C Preparation of astaxanthin and intermediate thereof
04/2000
04/27/2000WO2000023433A1 Substituted benzopyran analogs for the treatment of inflammation
04/27/2000CA2347910A1 Substituted benzopyran analogs for the treatment of inflammation
04/26/2000EP0703909B1 Delta 6,7 -taxols antineoplastic use and pharmaceutical compositions containing them
04/25/2000US6054475 Substituted dihydrobenzofuran-based phosphodiesterase 4 inhibitors useful for treating airway disorders
04/25/2000US6054437 Method for inducing death of neoplastic cells using piperazine derivatives
04/25/2000CA2010827C Use of derivates of n-phenyl-3,4,5,6-tetrahydrophthalimide for the desiccation and abscission of plant organs
04/20/2000WO2000021927A2 Pyrrole-2,5-diones as gsk-3 inhibitors
04/19/2000EP0994112A1 Method for separating contaminants from 3-(2'-acetoxy-ethyl)-dihydro-2(3h)furanone
04/19/2000EP0738262B1 Novel heterocyclic compounds
04/19/2000CN1051560C Method for preparing chelate of antibiotic and complex metallic salt
04/18/2000US6051724 An antileukemia and antitumor agents
04/18/2000US6051599 Endothelin receptor antagonists
04/13/2000WO2000020358A2 NON-PEPTIDE GnRH AGENTS, METHODS AND INTERMEDIATES FOR THEIR PREPARATION
04/13/2000CA2341346A1 Non-peptide gnrh agents, methods and intermediates for their preparation
04/12/2000EP0992492A1 Small molecule inhibitors of rotamase enzyme activity
04/12/2000EP0991692A1 Novel monomers with dilactonic cycle, and corresponding polymers
04/12/2000CN1051315C Phosphonooxymethyl ethers of taxane derivatives
04/12/2000CN1051310C Furyl or thienyl carbonyl substituted taxanes and pharmaceutical composition containing same
04/12/2000CN1051309C Fluoro taxols
04/11/2000CA1340952C Chemiluminescent 1,2-dioxetane compounds
03/2000
03/30/2000WO2000017184A1 Hydroxyflavone derivatives as tau protein kinase 1 inhibitors
03/30/2000CA2345311A1 Hydroxyflavone derivatives as tau protein kinase 1 inhibitors
03/29/2000EP0989114A1 N,n-disubstituted amic acid derivatives
03/29/2000CN1050839C Sulfonylamino pyrimidines compounds, medicinal composition containing same, its preparation process and use
03/28/2000US6043264 Benzene-condensed heterocyclic derivatives and their uses
03/28/2000US6043239 Heterocyclic compounds
03/28/2000CA2164152C New compounds of the secomacrolide and secoazalide class and a process for the preparation thereof
03/23/2000WO2000015634A2 Hiv protease inhibitors
03/23/2000WO2000015629A1 Polymerizable polyalkoxylated naphthopyrans
03/23/2000WO2000015628A1 Naphthopyrans annelated in c5-c6, their preparation and compositions and (co) polymer matrices containing them
03/23/2000WO2000015623A1 Syntheses of 5,5'-diformyl-2-2'difuran and derivatives thereof
03/23/2000CA2342338A1 Naphthopyrans annelated in c5-c6, their preparation and compositions and (co) polymer matrices containing them
03/23/2000CA2339275A1 5,6-dihydro-4-hydroxy-2-pyranones as hiv aspartyl protease inhibitors
03/23/2000CA2310102A1 Syntheses of 5,5'-diformyl-2,2'difuran and derivatives thereof
03/22/2000EP0986552A1 5-naphthalen-1-yl-1,3-dioxane derivatives, preparation and therapeutic application
03/22/2000CN1050603C Prepn. of intermediate product used in process for diastereoselective synthesis of nucleosides
03/16/2000WO2000014085A1 Oxygenic heterocyclic compounds
03/16/2000WO2000014073A1 Benzodiazepinone derivatives, preparation method and intermediates therefor, use as medicines and compositions
03/16/2000WO1999067252A3 Epothilone derivatives and their synthesis and use
03/15/2000CN1247537A Sulfonamide compounds having 5-HT receptor activity
03/14/2000US6037350 Farnesyl protein transferase inhibiting (imidazol-5-yl)methyl-2-quionlinone derivatives
03/09/2000WO2000013026A1 Energy transfer dyes
03/09/2000WO2000012496A1 Novel cdk inhibitors having flavone structure
03/09/2000WO2000012494A1 Apoptosis inducing agents
03/09/2000WO2000012077A1 Potassium channel inhibitors and method
03/09/2000WO2000012075A1 Nitrosated and nitrosylated alpha-adrenergic receptor antagonists, compositions and methods of use
03/09/2000CA2342325A1 An agent for inducing apoptosis
03/09/2000CA2339145A1 Nitrosated and nitrosylated alpha-adrenergic receptor antagonists, compositions and methods of use
03/08/2000EP0983255A1 Substituted 2-benzoyl-cyclohexane-1,3-diones
03/08/2000CN1246862A Epothilone analogs
03/07/2000US6034256 Substituted benzopyran derivatives for the treatment of inflammation
03/07/2000US6034121 Agriculture
03/02/2000WO2000010993A1 Diarylbenzopyran derivatives as cyclooxygenase-2 inhibitors
03/02/2000WO2000010991A1 Inhibition and treatment of hepatitis b virus and flavivirus by helioxanthin and its analogs
03/02/2000WO2000010975A1 Oxindole derivatives as growth hormone releasers
03/02/2000WO2000010965A2 Quaternary ammonium salts and their use as anti-hiv agents
03/02/2000CA2341540A1 Inhibition and treatment of hepatitis b virus and flavivirus by helioxanthin and its analogs
03/02/2000CA2337307A1 Quaternary ammonium salts and their use
03/01/2000EP0982302A2 Delta 6,7-taxols antineoplastic use and pharmaceutical compositions containing them
03/01/2000EP0982301A2 Delta 6,7-taxols antineoplastic use and pharmaceutical compositions containing them
03/01/2000EP0981276A1 6-halo-or nitrate-substituted paclitaxels
02/2000
02/29/2000US6031099 Piperidine derivates having anxiolytic effect
02/29/2000US6030951 For treating tumors in mammals
02/23/2000EP0980867A1 Ketone derivatives and medicinal use thereof
02/23/2000EP0980866A2 Phenyl heterocycles as cyclooxygenase-2 inhibitors
02/23/2000EP0794952B1 Polymerisable aromatic carboxylic acid and carboxylic acid anhydrides with cyclic carbonate groups and compositions that contain these compounds
02/23/2000CN1245490A Sulfonyl urea derivatives and their use in control of interleukin-1 activity
02/22/2000US6028205 Antileukemia and antitumor agents as cancer chemotherapeutic agents
02/17/2000WO2000008007A2 Cyclopentabenzofuran derivatives and their use
02/17/2000WO2000007999A1 Triazolone derivatives, use thereof, and intermediate therefor
02/17/2000CA2339270A1 Triazolone derivatives, use thereof, and intermediate therefor
02/16/2000CN1244860A Cyclic imines as pesticides
02/16/2000CN1049433C 6,7-modified paclitaxels and medicinal composition containing said compound
02/15/2000US6025491 Water soluble onium salt of taxo-diterpenoid
02/15/2000US6025392 substituted tetrahydrofuran analogs of prostaglandins as ocular hypotensives
02/15/2000US6025350 C-4" substituted macrolide antibiotics
02/10/2000DE19835324A1 Cyclopentabenzofuran-Derivate und ihre Verwendung Cyclopentabenzofuran derivatives and their use
02/09/2000EP0977748A1 Substituted benzopyran derivatives for the treatment of inflammation
02/08/2000US6022888 Iridoid derivatives and neovascularization inhibitors containing the same as active ingredient
02/08/2000US6022731 Genetically engineered plasmid that expresses a synthetases which is useful in producing copmounds that function as antibiotics, antitumor agents, or immunosuppressants
02/08/2000CA2014467C 3-substituted-2-oxindole derivatives
02/02/2000CN1048982C Method for semi-synthesis of taxalkane derivative with metal alkane oxide and beta-lactum
02/01/2000US6020366 Butyric acid matrix metalloproteinase inhibitors
01/2000
01/27/2000WO2000004011A1 Cyclic compounds useful in the treatment of dyslipidaemia, atherosclerosis and diabetes, pharmaceutical compositions and preparation process
01/27/2000WO1999058527A3 Benzofuran derivatives, pharmaceutical composition containing the same, and a process for the preparation of the active ingredient
01/27/2000CA2337481A1 Cyclic compounds useful in the treatment of dyslipidaemia, atherosclerosis and diabetes, pharmaceutical compositions and preparation process
01/26/2000EP0973756A1 Thiodepsipeptides for combating endoparasites and a method for producing the same
01/26/2000EP0643051B1 Process for Producing Alfa, Beta-Unsaturated Ketones
01/26/2000CN1242771A Ketone derivatives and medicinal use thereof
01/26/2000CN1242770A Cyclic ketone derivative and pharmaceutical use thereof
01/25/2000US6017956 N,N-disubstituted amic acid derivatives
01/25/2000US6017954 Angiogenesis inhibitors for treating and preventing angiogenesis-dependent tumors, especially kaposi's sarcoma, breast cancer, colon cancer
01/25/2000US6017952 Endothelin receptor antagonists
01/25/2000US6017951 Butenolide endothelin antagonists
01/25/2000US6017916 Nonpeptide endothelin antagonists I
1 ... 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 ... 120